Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
- Conditions
- First Posted Date
- 2007-09-12
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 10
- Registration Number
- NCT00528853
- Locations
- 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
Statins for the Early Treatment of Sepsis
- First Posted Date
- 2007-09-12
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 68
- Registration Number
- NCT00528580
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
- Conditions
- Interventions
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 15
- Registration Number
- NCT00523432
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2014-02-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 30
- Registration Number
- NCT00523640
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Family Therapy for Adolescent Bulimia Nervosa
- First Posted Date
- 2007-08-21
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 80
- Registration Number
- NCT00518843
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
- First Posted Date
- 2007-08-21
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 44
- Registration Number
- NCT00519077
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer
- First Posted Date
- 2007-08-16
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 11
- Registration Number
- NCT00517361
- Locations
- 🇺🇸
Oncology Specialists, Park Ridge, Illinois, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Vaccination Plus Ontak in Patients With Metastatic Melanoma
- First Posted Date
- 2007-08-13
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 17
- Registration Number
- NCT00515528
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
- Conditions
- Interventions
- First Posted Date
- 2007-08-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 273
- Registration Number
- NCT00515281
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer
- First Posted Date
- 2007-08-13
- Last Posted Date
- 2014-06-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 6
- Registration Number
- NCT00515112
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
🇺🇸Northwestern University, Chicago, Illinois, United States